AQEMIA
LIVE

Serial Number

99036315

Owner

AQEMIA

Attorney

Pina Campagna

Filing Date

Feb 11, 2025

Add to watchlist:

No watchlists yet
View on USPTO

AQEMIA Trademark

Serial Number: 99036315

AQEMIA is a trademark filed by AQEMIA on February 11, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

AQEMIA

231 rue Saint-Honoré
Paris 75001 , FR

Entity Type: 34

Trademark Details

Filing Date

February 11, 2025

Registration Date

Not Registered

Published for Opposition

June 16, 2026

Goods & Services

Recorded computer software for the discovery and development of new molecules using quantum physics methods; Downloadable computer software for the discovery and development of new molecules using quantum physics methods; Downloadable computer software for use in conducting molecular research; Downloadable computer software for use in the research and development of pharmaceutical products for the treatment of pain, viral diseases, coronavirus, herpes, hepatitis, cancer, lung cancer, pancreatic cancer, hematological cancer, colorectal cancer, breast cancer, bladder cancer, cervical cancer, gynecologic cancer, head and neck cancer, kidney cancer, liver cancer, myeloma, ovarian cancer, prostate cancer, skin cancer, thyroid cancer, uterine cancer, neurological cancer, mental and physical disorders and conditions, schizophrenia, mental health disorders, eating disorders and addictions, nicotine addiction, skin conditions, dermatitis, skin pigmentation diseases, psoriasis, eczema, respiratory infections, eye infections, bacterial and parasitic infections, malaria, tuberculosis, respiratory conditions, anxiety, arthritis, neurological diseases, Huntington's disease, cerebral palsy, brain injury, spinal cord injury, seizure disorders, immunologic diseases and disorders, Alzheimer's, Parkinson's disease, ulcerative colitis, multiple sclerosis, immuno-oncological diseases, atopic dermatitis, asthma, inflammatory bowel diseases (IBD), systemic lupus erythematosus (SLE), chronic obstructive pulmonary diseases (COPD), diabetes, hypercholesterolemia, thyroid disorders, hypothyroidism, hyperthyroidism, musculoskeletal diseases, bone diseases, central nervous system (CNS) diseases, peripheral nervous system (PNS) diseases, cardiovascular diseases and disorders, fertility disorders, endometriosis, pregnancy-related conditions, eye conditions, glaucoma, cataracts, macular degeneration, liver diseases, cirrhosis, fatty liver disease, kidney diseases, chronic kidney disease, renal insufficiency, gastrointestinal disorders, irritable bowel syndrome (IBS), Crohn's disease, reflux, ulcers, gastritis, hematological disorders, anemia, hemophilia, genetic diseases, cystic fibrosis, pediatric diseases, urological disorders, incontinence, benign prostatic hyperplasia, inflammation, enzyme deficiencies; Downloadable computer software for molecular modeling and simulation based on quantum physics principles; Downloadable computer software for use in scientific project management; Downloadable computer software for the design of chemical structures; Downloadable computer software for the analysis of biological and chemical activities; Downloadable computer software and recorded computer software using artificial intelligence for use in scientific research and development, molecular discovery, pharmaceutical research, diagnosing diseases and conditions, molecular modeling, project management, biological and chemical analysis, virtual screening of compounds, and efficacy and toxicity prediction; Downloadable computer software for use in virtual screening of compounds, toxicology, and analysis of diagnostic results based on quantum physics; Recorded computer software for use in molecular research; Recorded computer software for use in the research and development of pharmaceutical products for the treatment of pain, viral diseases, coronavirus, herpes, hepatitis, cancer, lung cancer, pancreatic cancer, hematological cancer, colorectal cancer, breast cancer, bladder cancer, cervical cancer, gynecologic cancer, head and neck cancer, kidney cancer, liver cancer, myeloma, ovarian cancer, prostate cancer, skin cancer, thyroid cancer, uterine cancer, neurological cancer, mental and physical disorders and conditions, schizophrenia, mental health disorders, eating disorders and addictions, nicotine addiction, skin conditions, dermatitis, skin pigmentation diseases, psoriasis, eczema, respiratory infections, eye infections, bacterial and parasitic infections, malaria and tuberculosis, respiratory conditions, anxiety, arthritis, neurological diseases, Huntington's disease, cerebral palsy, brain injury, spinal cord injury, seizure disorders, immunologic diseases and disorders, Alzheimer's, Parkinson's disease, ulcerative colitis, multiple sclerosis, immuno-oncological diseases, atopic dermatitis, asthma, inflammatory bowel diseases (IBD), systemic lupus erythematosus (SLE), chronic obstructive pulmonary diseases (COPD), diabetes, hypercholesterolemia, thyroid disorders, hypothyroidism, hyperthyroidism, musculoskeletal diseases, bone diseases, central nervous system (CNS) diseases, peripheral nervous system (PNS) diseases, cardiovascular diseases and disorders, fertility disorders, endometriosis, pregnancy related conditions, eye conditions, glaucoma, cataracts, macular degeneration, liver diseases, cirrhosis, fatty liver disease, kidney diseases, chronic kidney disease, renal insufficiency, gastrointestinal disorders, irritable bowel syndrome (IBS), Crohn's disease, reflux, ulcers, gastritis, hematological disorders, anemia, hemophilia, genetic diseases, cystic fibrosis, pediatric diseases, urological disorders, incontinence, benign prostatic hyperplasia, inflammation, enzyme deficiencies; Recorded computer software for cell analysis; Downloadable computer software for cell analysis; Recorded computer software for molecular modeling and simulation based on quantum physics principles; Recorded computer software for use in scientific project management; Recorded computer software for designing chemical structures; Recorded computer software for the analysis of biological or chemical activities; Recorded and downloadable computer software using artificial intelligence (AI) for pharmaceuticals research, and diagnostics of diseases and conditions; Recorded computer software for use in scientific research and development, molecular discovery, pharmaceutical research

Pharmaceutical preparations for the treatment of pain, viral diseases, coronavirus, herpes, hepatitis, cancer, lung cancer, pancreatic cancer, hematological cancer, colorectal cancer, breast cancer, bladder cancer, cervical cancer, gynecologic cancer, head and neck cancer, kidney cancer, liver cancer, myeloma, ovarian cancer, prostate cancer, skin cancer, thyroid cancer, uterine cancer, neurological cancer, schizophrenia, mental health disorders, eating disorders and addictions, nicotine addiction, dermatitis, skin pigmentation diseases, psoriasis, eczema, respiratory infections, eye infections, bacterial and parasitic infections, malaria and tuberculosis, respiratory conditions, anxiety, arthritis, neurological diseases, Huntington's disease, cerebral palsy, brain injury, spinal cord injury, seizure disorders, immunologic diseases and disorders, Alzheimer's, Parkinson's disease, ulcerative colitis, multiples sclerosis, immuno-oncological diseases, atopic dermatitis, asthma, inflammatory bowel diseases (IBD), systemic lupus erythematosus (SLE), chronic obstructive pulmonary diseases (COPD), diabetes, hypercholesterolemia, thyroid disorders, musculoskeletal diseases, bone diseases, peripheral nervous system (PNS) diseases, cardiovascular diseases and disorders, fertility disorders, endometriosis, pregnancy-related conditions in the nature of gestational diabetes, preeclampsia, hypertension, edema, and acid reflux (GERD), eye conditions, glaucoma, cataracts, macular degeneration, liver diseases, cirrhosis, fatty liver disease, kidney diseases, chronic kidney disease, renal insufficiency, gastrointestinal disorders, irritable bowel syndrome (IBS), Crohn's disease, reflux, ulcers, gastritis, hematological disorders, anemia, hemophilia, genetic diseases, cystic fibrosis, pediatric diseases, urological disorders, incontinence, benign prostatic hyperplasia, inflammation, enzyme deficiencies; Medical preparations for the treatment of pain, viral diseases, coronavirus, herpes, hepatitis, cancer, lung cancer, pancreatic cancer, hematological cancer, colorectal cancer, breast cancer, bladder cancer, cervical cancer, gynecologic cancer, head and neck cancer, kidney cancer, liver cancer, myeloma, ovarian cancer, prostate cancer, skin cancer, thyroid cancer, uterine cancer, neurological cancer, schizophrenia, mental health disorders, eating disorders and addictions, nicotine addiction, dermatitis, skin pigmentation diseases, psoriasis, eczema, respiratory infections, eye infections, bacterial and parasitic infections, malaria, tuberculosis, respiratory conditions, anxiety, arthritis, neurological diseases, Huntington's disease, cerebral palsy, brain injury, spinal cord injury, seizure disorders, immunologic diseases and disorders, Alzheimer's, Parkinson's disease, ulcerative colitis, multiples sclerosis, immuno-oncological diseases, atopic dermatitis, asthma, inflammatory bowel diseases (IBD), systemic lupus erythematosus (SLE), chronic obstructive pulmonary diseases (COPD), diabetes, hypercholesterolemia, thyroid disorders, hypothyroidism, hyperthyroidism, musculoskeletal diseases, bone diseases, central nervous system (CNS) diseases, peripheral nervous system (PNS) diseases, cardiovascular diseases and disorders, fertility disorders, endometriosis, pregnancy-related conditions in the nature of gestational diabetes, preeclampsia, hypertension, edema, and acid reflux (GERD), eye conditions, glaucoma, cataracts, macular degeneration, liver diseases, cirrhosis, fatty liver disease, kidney diseases, chronic kidney disease, renal insufficiency, gastrointestinal disorders, irritable bowel syndrome (IBS), Crohn's disease, reflux, ulcers, gastritis, hematological disorders, anemia, hemophilia, genetic diseases, cystic fibrosis, pediatric diseases, urological disorders, incontinence, benign prostatic hyperplasia, inflammation, enzyme deficiencies; Veterinary pharmaceutical preparations for the treatment of pain, viral diseases, paramyxovirus, influenza A virus, coronavirus, herpes, hepatitis, wounds, cancer, lung cancer, pancreatic cancer, hematological cancer, colorectal cancer, breast cancer, bladder cancer, cervical cancer, gynecologic cancer, head and neck cancer, kidney cancer, liver cancer, myeloma, ovarian cancer, prostate cancer, skin cancer, thyroid cancer, uterine cancer, neurological cancer, mental health disorders, musculoskeletal diseases, bone diseases, central nervous system (CNS) diseases, cardiovascular diseases and disorders, skin conditions, dermatitis, skin pigmentation diseases, psoriasis, eczema, respiratory infections, eye infections, bacterial and parasitic infections, malaria and tuberculosis, respiratory conditions, arthritis, inflammatory diseases, inflammatory bowel diseases, inflammatory connective tissue diseases, immunologic diseases and disorders, Alzheimer's, ulcerative colitis, immuno-oncological diseases, atopic dermatitis, asthma, inflammatory bowel diseases (IBD), systemic lupus erythematosus (SLE), chronic obstructive pulmonary diseases (COPD), allergies, anxiety; Veterinary vaccines for animals; Sanitary preparations for medical use; Dietetic foods adapted for medical use; Dietetic foods adapted for veterinary use; Food for babies; Dietary supplements for human beings and animals; Plasters for medical purposes; Antifungal preparations; Antivirals; Antibiotics; Sanitary preparations for medical purposes; Dietetic foods adapted for medical purposes; Dietetic foods adapted for veterinary purposes

(Based on Section 44e) Scientific and technological services, namely, scientific research, analysis, data modeling, testing in the field of pharmaceuticals and molecule design; pharmacological research and analysis; Research laboratory analysis services in the field of pharmaceutical products, molecule design using artificial intelligence; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control of biological data, laboratory data, and research results, in the field of molecules, pharmaceuticals, pharmacological research; Design and development of computer software; Computer software development in the field of algorithms for drug discovery; Research laboratory analysis services in the field of bioinformatics; Product design and development in the field of computer assisted molecule design for pharmaceutical purposes; Research and development of new products; Research and development in the field of medical preparations; Chemical, biochemical, biological and bacteriological research and analysis; Research and development in the field of pharmaceutical preparations; (Based on Intent to Use) Providing virtual computer systems through cloud computing; Technology consultation in the field of cloud computing for drug discovery and development; Consulting services in the field of pharmaceutical research and development; Technology consultation in the field of artificial intelligence for drug design

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 16, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 16, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 15, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
May 15, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 15, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
May 15, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 15, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 22, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 28, 2026 GNFN
FINAL REFUSAL E-MAILED
Jan 28, 2026 GNFR
FINAL REFUSAL WRITTEN
Jan 28, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 7, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 11, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 11, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 11, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 18, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 11, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2025 NWOS
NEW APPLICATION ENTERED
Feb 11, 2025 NWAP